跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REVISEA 80 MG CÁPSULAS BLANDAS - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
REVISEA 80 MG CÁPSULAS BLANDAS
Approved
STANDARD
REVISEA 80 MG CÁPSULAS BLANDAS
Kern Pharma S.L.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 15, 2024
Approval ID
7628f1c2e69a2ee9
Company
Kern Pharma S.L.
Type
Standard
Approval Details
Approval Id
7628f1c2e69a2ee9
Drug Cima Aemps Name
REVISEA 80 MG CÁPSULAS BLANDAS
Register Number
89352
Holder Company Name
Kern Pharma S.L.
Marketing Company Name
Kern Pharma S.L.
Holder Company Detail Path
/organization/kern-pharma-s-l
Marketing Company Detail Path
/organization/kern-pharma-s-l
Authorization Date
2024-02-15
Dosage Form
CÁPSULA BLANDA
Dose
80 mg
Route Of Administration
VÍA ORAL
Prescription Type
Sin Receta
Commercialized
Yes
Company Name
Kern Pharma S.L.
Company Detail Path
/organization/kern-pharma-s-l
Company Information
Pharmaceutical Company Name
Kern Pharma S.L.
Country Name
Dominican Republic
Active Ingredients
LAVANDA, ACEITE ESENCIAL DE
80 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 15, 2024
Approval ID
7628f1c2e69a2ee9
Type
Standard
Back to CIMA-AEMPS Approvals